Clinical Trials
4 trialsNCT02194231 2020-01-23
ATREUS
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT00027508 2015-02-24
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
PharmaMar
Phase 2 Terminated
NCT00006463 2014-02-21
Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00002904 2012-07-02
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed